» Articles » PMID: 17130167

Evidence of the Neuron-restrictive Silencer Factor (NRSF) Interaction with Sp3 and Its Synergic Repression to the Mu Opioid Receptor (MOR) Gene

Overview
Specialty Biochemistry
Date 2006 Nov 30
PMID 17130167
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, we reported that the neuron-restrictive silencer element (NRSE) of mu opioid receptor (MOR) functions as a critical regulator to repress the MOR transcription in specific neuronal cells, depending on neuron-restriction silence factor (NRSF) expression levels [C.S.Kim, C.K.Hwang, H.S.Choi, K.Y.Song, P.Y.Law, L.N. Wei and H.H.Loh (2004) J. Biol. Chem., 279, 46464-46473]. Herein, we identify a conserved GC sequence next to NRSE region in the mouse MOR gene. The inhibition of Sp family factors binding to this GC box by mithramycin A led to a significant increase in the endogenous MOR transcription. In the co-immunoprecipitation experiment, NRSF interacted with the full-length Sp3 factor, but not with Sp1 or two short Sp3 isoforms. The sequence specific and functional binding by Sp3 at this GC box was confirmed by in vitro gel-shift assays using either in vitro translated proteins or nuclear extract, and by in vivo chromatin immunoprecipitation assays. Transient transfection assays showed that Sp3-binding site of the MOR gene is a functionally synergic repressor element with NRSE in NS20Y cells, but not in the NRSF negative PC12 cells. The results suggest that the synergic interaction between NRSF and Sp3 is required to negatively regulate MOR gene transcription and that transcription of MOR gene would be governed by the context of available transcription factors rather than by a master regulator.

Citing Articles

REST Is Not Resting: REST/NRSF in Health and Disease.

Jin L, Liu Y, Wu Y, Huang Y, Zhang D Biomolecules. 2023; 13(10).

PMID: 37892159 PMC: 10605157. DOI: 10.3390/biom13101477.


Human OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types.

Salimando G, Tremblay S, Kimmey B, Li J, Rogers S, Wojick J Nat Commun. 2023; 14(1):5632.

PMID: 37704594 PMC: 10499891. DOI: 10.1038/s41467-023-41407-2.


Antinociceptive effect of intrathecal injection of miR-9-5p modified mouse bone marrow mesenchymal stem cells on a mouse model of bone cancer pain.

Zhu C, Wang K, Chen Z, Han Y, Chen H, Li Q J Neuroinflammation. 2020; 17(1):85.

PMID: 32178691 PMC: 7075036. DOI: 10.1186/s12974-020-01765-w.


NRSF and Its Epigenetic Effectors: New Treatments for Neurological Disease.

Thompson R, Chan C Brain Sci. 2018; 8(12).

PMID: 30572571 PMC: 6316267. DOI: 10.3390/brainsci8120226.


Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats.

He X, Zhou K, Zhao W, Zhang C, Deng J, Chen F Front Pharmacol. 2018; 9:509.

PMID: 29867508 PMC: 5962808. DOI: 10.3389/fphar.2018.00509.


References
1.
Li L, He S, Sun J, Davie J . Gene regulation by Sp1 and Sp3. Biochem Cell Biol. 2004; 82(4):460-71. DOI: 10.1139/o04-045. View

2.
Hwang C, Kim C, Choi H, McKercher S, Loh H . Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J Biol Chem. 2004; 279(19):19764-74. DOI: 10.1074/jbc.M400755200. View

3.
Blume S, SNYDER R, Ray R, Thomas S, Koller C, Miller D . Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest. 1991; 88(5):1613-21. PMC: 295684. DOI: 10.1172/JCI115474. View

4.
. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993; 72(6):971-83. DOI: 10.1016/0092-8674(93)90585-e. View

5.
Wood P . The significance of multiple CNS opioid receptor types: a review of critical considerations relating to technical details and anatomy in the study of central opioid actions. Peptides. 1988; 9 Suppl 1:49-55. DOI: 10.1016/0196-9781(88)90223-9. View